Trevena INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
OTC.Pink
TRVN
Trevena INCTrevena Inc. reported its Q3 2024 financial results, highlighting a net loss and ongoing strategic review, alongside significant cost-cutting measures including executive departures and a reverse stock split.
OTC.Pink
TRVN
Trevena INCTrevena Inc. announced its second quarter 2024 financial results, highlighting a strategic review process and reduced commercial support for its lead product, OLINVYK.
OTC.Pink
TRVN
Trevena INCTrevena Inc. announced its first quarter 2024 financial results, highlighting a strategic review of its commercial operations for OLINVYK and ongoing efforts to maintain Nasdaq listing compliance.